Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCPF1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,168
Award facts
- Contract value 100% obligated
- $33,168.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $33,168.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This delivery order, awarded on December 30, 2025, with an ultimate completion date of January 22, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The work will be performed in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense military healthcare facilities worldwide. The prime contract, designated SPE2DR and awarded November 13, 2025, features a 30-month base period with three 30-month option periods extending through December 31, 2036. DMS Pharmaceutical Group serves as a regional prime vendor under this broader initiative, positioning the company as a critical supplier for the military medical system's diverse pharmaceutical requirements. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FCPF1?
SPE2DR26FCPF1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FCPF1 worth?
The government has obligated $33,168 on SPE2DR26FCPF1.
Is contract SPE2DR26FCPF1 an order under another contract?
Yes. SPE2DR26FCPF1 is a delivery order under SPE2DR25D9131, an indefinite delivery contract.
Was contract SPE2DR26FCPF1 competed?
The extent of competition for SPE2DR26FCPF1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award